Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity.
about
In vitro and in vivo evidence for amphotericin B as a P-glycoprotein substrate on the blood-brain barrier.Treatment options in Invasive Aspergillosis.Chronic Invasive Aspergillus Sinusitis and Otitis with Meningeal Extension Successfully Treated with Voriconazole.Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions.What can we learn and what do we need to know amidst the iatrogenic outbreak of Exserohilum rostratum meningitis?Tissue penetration of antifungal agents.Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes.Reflections on the approach to treatment of a mycologic disaster.Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis.Toxicity and efficacy differences between liposomal amphotericin B formulations in uninfected and Aspergillus fumigatus infected mice.Very-high-dose caspofungin combined with voriconazole to treat central nervous system aspergillosis: substantial penetration of caspofungin into cerebrospinal fluid.Relation between Skin Pharmacokinetics and Efficacy in AmBisome Treatment of Murine Cutaneous Leishmaniasis.CNS Mold Infections.
P2860
Q34058209-68008665-41C3-497B-8F1F-F56329B40A4BQ34357504-E9D17A8D-C556-4588-9F8E-45BA4EBF344CQ36290477-5384EEFB-175F-40FB-94DC-6006F3387AF1Q36868273-7B35512D-C5E2-47B6-9603-A0F0462B6B4AQ37463387-02B855B3-0239-4B73-BC28-1BFEC09764C9Q37544911-5BED68F7-8405-4E65-BDCA-80DB33044FC2Q38586680-8901F920-16FE-4220-9CD1-5FA98E5970F0Q39767419-2B893135-AB60-4519-A50E-25B64513AA66Q40287344-F61D6842-20D8-41C5-BB8A-3FBE554D6C26Q41570433-8B91BDEE-15CF-41C1-83D7-4F55B0AA581FQ42706754-153820B1-4FD4-4EA7-9106-441216CA8FFCQ51771412-57CC1712-4768-480A-A210-8958980E500BQ54767163-7FC7C1EF-3199-446B-9977-6BCE7B04EE18
P2860
Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Experimental central nervous s ...... ohistopathology, and toxicity.
@en
Experimental central nervous s ...... ohistopathology, and toxicity.
@nl
type
label
Experimental central nervous s ...... ohistopathology, and toxicity.
@en
Experimental central nervous s ...... ohistopathology, and toxicity.
@nl
prefLabel
Experimental central nervous s ...... ohistopathology, and toxicity.
@en
Experimental central nervous s ...... ohistopathology, and toxicity.
@nl
P2093
P2860
P356
P1476
Experimental central nervous s ...... ohistopathology, and toxicity.
@en
P2093
David A Stevens
Julie A Schwartz
Karl V Clemons
P2860
P304
P356
10.1128/AAC.06015-11
P407
P577
2012-06-11T00:00:00Z